...
首页> 外文期刊>American Journal of Physiology >Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus.
【24h】

Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus.

机译:用二甲基硫脲治疗可防止糖尿病期间基底动脉的扩张受损。

获取原文
获取原文并翻译 | 示例

摘要

The goal of this study was to test the hypothesis that the synthesis/release of hydroxyl radical accounts for impaired nitric oxide synthase-dependent dilatation of the basilar artery during diabetes mellitus. We measured the diameter of the basilar artery in vivo in nondiabetic and diabetic rats (streptozotocin, 50-60 mg/kg ip) in response to nitric oxide synthase-dependent agonists (acetylcholine and substance P) and a nitric oxide synthase-independent agonist (nitroglycerin). Reactivity of the basilar artery was measured in untreated nondiabetic and diabetic rats and in nondiabetic and diabetic rats treated with a daily intraperitoneal injection of dimethylthiourea (DMTU; 50 mg/kg). Injection of DMTU was started 48 h after injection of streptozotocin and was continued throughout the diabetic period (3-4 wk). Topical application of acetylcholine (0.1, 1.0, and 10 microM) and substance P (0.1 and 1.0 microM) produced similar dilatation of the basilar artery in untreated and DMTU-treated nondiabetic rats. In untreated diabetic rats, the magnitude of vasodilation produced by acetylcholine and substance P was significantly less than in untreated nondiabetic rats. However, in DMTU-treated diabetic rats, dilatation of the basilar artery in response to acetylcholine and substance P was similar to that observed in nondiabetic rats. Dilatation of the basilar artery in response to nitroglycerin was similar in untreated and DMTU-treated nondiabetic and diabetic rats. These findings suggest that impaired nitric oxide synthase-dependent dilatation of the basilar artery during diabetes mellitus may be related to the synthesis/release of hydroxyl radical.
机译:这项研究的目的是检验以下假设:羟自由基的合成/释放是糖尿病患者基底动脉一氧化氮合酶依赖性扩张受损的原因。我们测量了一氧化氮合酶依赖性激动剂(乙酰胆碱和P物质)和一氧化氮合酶依赖性激动剂(非糖尿病和糖尿病大鼠,链脲佐菌素,50-60 mg / kg腹膜内)的基底动脉的直径。硝酸甘油)。在未治疗的非糖尿病和糖尿病大鼠以及每天腹膜内注射二甲基硫脲(DMTU; 50 mg / kg)治疗的非糖尿病和糖尿病大鼠中,测量了基底动脉的反应性。注射链脲佐菌素后48小时开始注射DMTU,并在整个糖尿病期间(3-4周)继续注射。在未经治疗和经DMTU治疗的非糖尿病大鼠中,局部应用乙酰胆碱(0.1、1.0和10 microM)和物质P(0.1和1.0 microM)会产生类似的基底动脉扩张。在未经治疗的糖尿病大鼠中,乙酰胆碱和P物质产生的血管舒张程度明显低于未经治疗的非糖尿病大鼠。但是,在用DMTU治疗的糖尿病大鼠中,响应于乙酰胆碱和P物质的基底动脉扩张与在非糖尿病大鼠中观察到的相似。在未治疗和DMTU治疗的非糖尿病和糖尿病大鼠中,响应硝酸甘油的基底动脉扩张相似。这些发现表明,糖尿病期间基底动脉一氧化氮合酶依赖性扩张受损可能与羟基自由基的合成/释放有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号